Beranda Label Genor Biopharma

Label: Genor Biopharma

Genor Biopharma Releases Its Annual Results for 2020

Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress - GB226 (Geptanolimab) Priority Review for PTCL, GB242 (infliximab (Remicade) biosimilar)...

BERITA POPULER